CARDIAC WEIGHT IN HYPERTENSION INDUCED BY NITRIC-OXIDE SYNTHASE BLOCKADE

被引:185
作者
ARNAL, JF
ELAMRANI, AI
CHATELLIER, G
MENARD, J
MICHEL, JB
机构
[1] INSERM Unit 367, 75005 Paris
关键词
GUANOSINE CYCLIC MONOPHOSPHATE; HEART HYPERTROPHY; NITRIC OXIDE; RENIN;
D O I
10.1161/01.HYP.22.3.380
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Wistar rats given a nitric oxide synthase inhibitor, N(G)-nitro-L-arginine-methyl ester (L-NAME), for 4 weeks develop time- and dose-dependent hypertension without cardiac hypertrophy. This initial study of the relation between left ventricular weight and L-NAME-induced hypertension has now been extended by giving 50 mg/kg per day L-NAME to Wistar rats (n=30) for 8 weeks and comparing results with those from control rats (n = 10) and two-kidney, one clip rats (n = 14). Although L-NAME rats and two-kidney, one clip rats had increased systolic blood pressures during the last 3 weeks of the experiment (202 +/- 24 and 224 +/- 16 mmHg, respectively), the ratio of left ventricular weight to body weight of L-NAME rats (2.12 +/- 0.32 mg/g) was not statistically different from that of control rats (1.93 +/- 0.13 mg/g), whereas that of two-kidney, one clip rats was increased (2.85 +/- 0.20 mg/g). The plasma renin activity of L-NAME rats was not significantly different from that of control rats. Two L-NAME rat subgroups were defined according to the presence of left ventricular hypertrophy (ratio of left ventricular weight to body weight > 2.19 mg/g, control mean + 2 SD) (6 of 25) or its absence (19 of 25). Systolic blood pressure, plasma renin activity, and cardiac angiotensin converting enzyme activity of L-NAME rats with left ventricular hypertrophy were significantly higher than those of the subgroup without. In a multiple regression analysis using the ratio of left ventricular weight to body weight as an independent variable and three dependent variables (L-NAME administration, plasma renin activity, and systolic blood pressure), we found that all of these three variables contributed to left ventricular weight independently of each other. Thus, even if the degree of left ventricular hypertrophy evolves in parallel with the duration and magnitude of a chronic rise in blood pressure, other factors, such as the renin-angiotensin system and nitric oxide production, influence this relation.
引用
收藏
页码:380 / 387
页数:8
相关论文
共 38 条
[1]   DETERMINANTS OF AORTIC CYCLIC GUANOSINE-MONOPHOSPHATE IN HYPERTENSION INDUCED BY CHRONIC INHIBITION OF NITRIC-OXIDE SYNTHASE [J].
ARNAL, JF ;
WARIN, L ;
MICHEL, JB .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (02) :647-652
[2]   CHRONIC BLOCKADE OF NITRIC-OXIDE SYNTHESIS IN THE RAT PRODUCES SYSTEMIC HYPERTENSION AND GLOMERULAR DAMAGE [J].
BAYLIS, C ;
MITRUKA, B ;
DENG, A .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) :278-281
[3]   EFFECTS OF PROPRANOLOL AND PINDOLOL ON PLASMA ANP LEVELS IN HUMANS AT REST AND DURING EXERCISE [J].
BOUISSOU, P ;
GALEN, FX ;
RICHALET, JP ;
LARTIGUE, M ;
DEVAUX, F ;
DUBRAY, C ;
ATLAN, G .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (02) :R259-R264
[4]  
BROWN JJ, 1976, LANCET, V1, P1219
[5]   EFFECTS OF DAMAGING THE ENDOCARDIAL SURFACE ON THE MECHANICAL PERFORMANCE OF ISOLATED CARDIAC-MUSCLE [J].
BRUTSAERT, DL ;
MEULEMANS, AL ;
SIPIDO, KR ;
SYS, SU .
CIRCULATION RESEARCH, 1988, 62 (02) :358-366
[6]   GUANOSINE 3',5'-CYCLIC-MONOPHOSPHATE ASSAY AT 10-15-MOLE LEVEL [J].
CAILLA, HL ;
VANNIER, CJ ;
DELAAGE, MA .
ANALYTICAL BIOCHEMISTRY, 1976, 70 (01) :195-202
[7]   ACTIONS OF ATRIAL-NATRIURETIC-PEPTIDE (ANP) ON CYCLIC-NUCLEOTIDE CONCENTRATIONS AND PHOSPHATIDYLINOSITOL TURNOVER IN VENTRICULAR MYOCYTES [J].
CRAMB, G ;
BANKS, R ;
RUGG, EL ;
AITON, JF .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 148 (03) :962-970
[8]   SPECTROPHOTOMETRIC ASSAY AND PROPERTIES OF ANGIOTENSIN-CONVERTING ENZYME OF RABBIT LUNG [J].
CUSHMAN, DW ;
CHEUNG, HS .
BIOCHEMICAL PHARMACOLOGY, 1971, 20 (07) :1637-+
[9]   ROLE OF GENETIC FACTORS IN SUSCEPTIBILITY TO EXPERIMENTAL HYPERTENSION DUE TO CHRONIC EXCESS SALT INGESTION [J].
DAHL, LK ;
HEINE, M ;
TASSINARI, L .
NATURE, 1962, 194 (4827) :480-&
[10]  
DUSSAULE JC, 1986, J PHARMACOL EXP THER, V236, P512